CN102115468B - 一种2,5-二取代噻吩化合物的合成方法 - Google Patents
一种2,5-二取代噻吩化合物的合成方法 Download PDFInfo
- Publication number
- CN102115468B CN102115468B CN200910247892.4A CN200910247892A CN102115468B CN 102115468 B CN102115468 B CN 102115468B CN 200910247892 A CN200910247892 A CN 200910247892A CN 102115468 B CN102115468 B CN 102115468B
- Authority
- CN
- China
- Prior art keywords
- compound
- amino
- glucopyranosyl
- hydroxyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 COC([C@@]([C@]1O)O)(c2ccc(*)c(C(c3ccc(-c(cc4)ccc4F)[s]3)=O)c2)O[C@@](CO)[C@@]1O Chemical compound COC([C@@]([C@]1O)O)(c2ccc(*)c(C(c3ccc(-c(cc4)ccc4F)[s]3)=O)c2)O[C@@](CO)[C@@]1O 0.000 description 2
- BKIKFMJVBOKQGL-ONEOHUSESA-N Cc1ccc(C([C@@H]([C@H]2O)O)(OC)O[C@H](CO)[C@H]2O)cc1C(c1ccc(-c(cc2)ccc2F)[s]1)=O Chemical compound Cc1ccc(C([C@@H]([C@H]2O)O)(OC)O[C@H](CO)[C@H]2O)cc1C(c1ccc(-c(cc2)ccc2F)[s]1)=O BKIKFMJVBOKQGL-ONEOHUSESA-N 0.000 description 2
- AXGQFHQHJAGCPW-NLKOSQCUSA-N CC(OC[C@H]([C@H]([C@@H]([C@H]1OC(C)=O)OC(C)=O)OC(C)=O)OC1(c1ccc(C)c(C(c2ccc(-c(cc3)ccc3F)[s]2)=O)c1)OC)=O Chemical compound CC(OC[C@H]([C@H]([C@@H]([C@H]1OC(C)=O)OC(C)=O)OC(C)=O)OC1(c1ccc(C)c(C(c2ccc(-c(cc3)ccc3F)[s]2)=O)c1)OC)=O AXGQFHQHJAGCPW-NLKOSQCUSA-N 0.000 description 1
- LGJPFMPWVTULHV-UHFFFAOYSA-N Cc(c(C(CCl)=O)c1)ccc1[N+]([O-])=O Chemical compound Cc(c(C(CCl)=O)c1)ccc1[N+]([O-])=O LGJPFMPWVTULHV-UHFFFAOYSA-N 0.000 description 1
- MMPQQTOUVXILPP-UHFFFAOYSA-N Cc(c(C(c1ccc(-c(cc2)ccc2F)[s]1)=O)c1)ccc1[N+]([O-])=O Chemical compound Cc(c(C(c1ccc(-c(cc2)ccc2F)[s]1)=O)c1)ccc1[N+]([O-])=O MMPQQTOUVXILPP-UHFFFAOYSA-N 0.000 description 1
- XTNGUQKDFGDXSJ-ZEVGPYTLSA-N Cc1ccc([C@@H]([C@@H](C2O)O)O[C@H](CO)[C@H]2O)cc1Cc1ccc(-c(cc2)ccc2F)[s]1 Chemical compound Cc1ccc([C@@H]([C@@H](C2O)O)O[C@H](CO)[C@H]2O)cc1Cc1ccc(-c(cc2)ccc2F)[s]1 XTNGUQKDFGDXSJ-ZEVGPYTLSA-N 0.000 description 1
- XTNGUQKDFGDXSJ-ZXGKGEBGSA-N Cc1ccc([C@@H]([C@@H]([C@H]2O)O)O[C@H](CO)[C@H]2O)cc1Cc1ccc(-c(cc2)ccc2F)[s]1 Chemical compound Cc1ccc([C@@H]([C@@H]([C@H]2O)O)O[C@H](CO)[C@H]2O)cc1Cc1ccc(-c(cc2)ccc2F)[s]1 XTNGUQKDFGDXSJ-ZXGKGEBGSA-N 0.000 description 1
- PMRMSGNJEJXYGD-UITAMQMPSA-N O=C/C=C(/c(cc1)ccc1F)\Cl Chemical compound O=C/C=C(/c(cc1)ccc1F)\Cl PMRMSGNJEJXYGD-UITAMQMPSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/04—Carbocyclic radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Abstract
Description
Claims (9)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910247892.4A CN102115468B (zh) | 2009-12-31 | 2009-12-31 | 一种2,5-二取代噻吩化合物的合成方法 |
PCT/CN2010/080357 WO2011079772A1 (zh) | 2009-12-31 | 2010-12-28 | 一种2,5-二取代噻吩化合物的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910247892.4A CN102115468B (zh) | 2009-12-31 | 2009-12-31 | 一种2,5-二取代噻吩化合物的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102115468A CN102115468A (zh) | 2011-07-06 |
CN102115468B true CN102115468B (zh) | 2014-06-11 |
Family
ID=44214408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910247892.4A Active CN102115468B (zh) | 2009-12-31 | 2009-12-31 | 一种2,5-二取代噻吩化合物的合成方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN102115468B (zh) |
WO (1) | WO2011079772A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104926803A (zh) * | 2015-06-17 | 2015-09-23 | 南通常佑药业科技有限公司 | 一种新的sglt2抑制剂药物的制备方法 |
WO2016008351A1 (zh) * | 2014-07-18 | 2016-01-21 | 上海科胜药物研发有限公司 | 一种坎格列净中间体2-(2-甲基-5-溴苄基)-5-(4-氟苯)噻吩的制备方法 |
WO2016098016A1 (en) * | 2014-12-17 | 2016-06-23 | Dr. Reddy’S Laboratories Limited | Process for the preparation of sglt2 inhibitors |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104557894A (zh) * | 2013-10-18 | 2015-04-29 | 上海信谊药厂有限公司 | 坎格列汀晶型及其制备方法 |
US9884839B2 (en) | 2014-01-03 | 2018-02-06 | Elexopharm Gmbh | Inhibitors of 17Beta-hydroxysteroid dehydrogenases type 1 and type 2 |
EP2918579A1 (en) | 2014-03-14 | 2015-09-16 | LEK Pharmaceuticals d.d. | Synthesis of 2-arylmethyl-5-aryl-thiophene |
CN103936725B (zh) * | 2014-04-01 | 2016-07-27 | 天津大学 | 卡格列净的c晶型及其结晶制备方法 |
CN103980263B (zh) * | 2014-04-17 | 2016-08-03 | 海门瑞一医药科技有限公司 | 卡格列净的合成工艺 |
WO2015181692A1 (en) * | 2014-05-27 | 2015-12-03 | Glenmark Pharmaceuticals Limited | Process for preparation of canagliflozin |
CN104086523A (zh) * | 2014-06-09 | 2014-10-08 | 上海方楠生物科技有限公司 | 一种制备坎格列净中间体2-(4-氟苯基)-5-[(5-卤代-2-甲基苯基)甲基]噻吩的方法 |
WO2016035042A1 (en) | 2014-09-05 | 2016-03-10 | Mylan Laboratories Ltd | Process for the preparation of canagliflozin |
CN104311532B (zh) * | 2014-10-31 | 2016-04-20 | 山东大学 | 2-(4-氟苯基)-5-[(5-溴-2-甲基苯基)甲基]噻吩的制备方法 |
EP3262039A4 (en) | 2015-02-27 | 2018-11-14 | MSN Laboratories Private Limited | Process for the preparation of amorphous (1s)-1,5-anhvdro-1-[3-[[5-(4 fluorophennyl)-2-thienyl]methvl]-4-methylphenyl]-d-glucitol and its polymorphs thereof |
CN104987320A (zh) * | 2015-08-03 | 2015-10-21 | 沧州那瑞化学科技有限公司 | 一种坎格列净中间体的制备方法 |
CN105130952A (zh) * | 2015-08-06 | 2015-12-09 | 杨海霞 | 一种医药中间体醛基取代噻吩化合物的合成方法 |
CN108976182A (zh) * | 2017-06-05 | 2018-12-11 | 上海奥博生物医药技术有限公司 | 一种制备达格列净五元环杂质的方法 |
CN108017612B (zh) * | 2017-11-29 | 2020-06-09 | 南通常佑药业科技有限公司 | 一种坎格列净中间体的制备方法 |
CN110950833A (zh) * | 2019-12-11 | 2020-04-03 | 台州学院 | 一种2-(4-氟苯基)-5-[(5-溴-2-甲基苯基)甲基]噻吩的制备方法 |
CN116162945B (zh) * | 2022-11-28 | 2023-08-04 | 安庆奇创药业有限公司 | 一种利用微反应装置连续电合成卡格列净中间体的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR045173A1 (es) * | 2003-08-01 | 2005-10-19 | Tanabe Seiyaku Co | Compuestos que poseen actividad inhibitoria contra transportador de glucosa dependiente de sodio |
UY30730A1 (es) * | 2006-12-04 | 2008-07-03 | Mitsubishi Tanabe Pharma Corp | Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno |
HUE035130T2 (en) * | 2007-09-10 | 2018-05-02 | Janssen Pharmaceutica Nv | A method for preparing compounds useful as SGLT inhibitors |
-
2009
- 2009-12-31 CN CN200910247892.4A patent/CN102115468B/zh active Active
-
2010
- 2010-12-28 WO PCT/CN2010/080357 patent/WO2011079772A1/zh active Application Filing
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016008351A1 (zh) * | 2014-07-18 | 2016-01-21 | 上海科胜药物研发有限公司 | 一种坎格列净中间体2-(2-甲基-5-溴苄基)-5-(4-氟苯)噻吩的制备方法 |
WO2016098016A1 (en) * | 2014-12-17 | 2016-06-23 | Dr. Reddy’S Laboratories Limited | Process for the preparation of sglt2 inhibitors |
CN104926803A (zh) * | 2015-06-17 | 2015-09-23 | 南通常佑药业科技有限公司 | 一种新的sglt2抑制剂药物的制备方法 |
CN104926803B (zh) * | 2015-06-17 | 2017-12-22 | 南通常佑药业科技有限公司 | 一种新的sglt2抑制剂药物的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102115468A (zh) | 2011-07-06 |
WO2011079772A1 (zh) | 2011-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102115468B (zh) | 一种2,5-二取代噻吩化合物的合成方法 | |
Prasad et al. | Cu-catalyzed in situ generation of thiol using xanthate as a thiol surrogate for the one-pot synthesis of benzothiazoles and benzothiophenes | |
US7951963B2 (en) | Process for production of 1-(3-(2-(1-benzothiophen-5-yl)-ethoxy)propyl)azetidin-3-ol or salts thereof | |
JP2600644B2 (ja) | チアゾリルベンゾフラン誘導体 | |
Lu et al. | Halocyclization of 2-alkynylthioanisoles by cupric halides: synthesis of 2-substituted 3-halobenzo [b] thiophenes | |
Soni et al. | Site‐Specific S‐Allylation of α‐Enolic Dithioesters with Morita‐Baylis‐Hillman Acetates at Room Temperature: Precursor for Thiopyrans | |
Kuhakarn et al. | Synthesis of alkylated indolizidine alkaloids via Pummerer mediated cyclization: synthesis of (±)-indolizidine 167B,(±)-5-butylindolizidine and (±)-monomorine I | |
Bergman et al. | Alkylation with oxalic esters. Scope and mechanism | |
Chamontin et al. | Synthesis and reactivity of formyl-substituted photochromic 3, 3-diphenyl-[3H]-naphtho [2, 1-b] pyrans | |
CN101959875B (zh) | 噻吩化合物及其中间体的制造方法 | |
Wang et al. | Synthesis of 2‐benzylthio‐5‐phenyl‐3, 4‐disubstituted thiophenes by intramolecular condensation of α‐oxo ketene dibenzyl‐thioacetals | |
CN104710417A (zh) | 氮杂吲哚类衍生物及其合成方法 | |
AU5878001A (en) | Novel benzothiophene derivatives | |
CN103333144A (zh) | 一种2-硫基-3-卤代苯并呋喃化合物及其合成方法和用途 | |
Burkamp et al. | Preparation of 3‐aminoalkylbenzo [b] thiophenes | |
Cul et al. | Evaluation of N‐hydroxymethylphthalimide in alkaline medium: Novel entry to the tricyclic [1, 3] oxazepine core via an intramolecular π and O‐cationic cyclization | |
Baldwin et al. | 5-Isothiazolidinonyl and 5-isoxazolidinonyl radicals: Approaches to the biogenetic-type synthesis of β-lactams | |
Katritzky et al. | Synthesis of 2, 4-disubstituted furans and 4, 6-diaryl-substituted 2, 3-benzo-1, 3a, 6a-triazapentalenes | |
Azzena et al. | Reductive lithiation of alkoxy-substituted benzyl methyl ethers and connection with cross-coupling reactions | |
CN100548990C (zh) | 苯并咪唑衍生物的制备方法 | |
Deprets et al. | New synthesis of substituted 6-methylbenzo [b] furo-,-thieno-, and-seleno [2, 3-c] quinolines, and heterocyclic analogues | |
Berg et al. | Cyanoacylation of 1-substituted isoquinolines and 3, 4-dihydroisoquinolines | |
Compagnini et al. | The reaction of benzylidenetriphenylphosphoranes with benzenediazonium‐2‐carboxylate | |
Fujii et al. | Synthesis and reactions of 3-and 8-ethynyl-1-azaazulenes | |
Mandal et al. | Studies in sulfur heterocycles. Part 14. 1 Application of heteroatom directed ortho-metallation in functionalisation of benzo [b] thiophene derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 201209 No. 1088, Chuansha Road, Shanghai, Pudong New Area Patentee after: Shanghai Tehua Medicine Science and Technology Co., Ltd. Patentee after: Shandong Topharman Pharmaceutical Co., Ltd. Address before: 201209 No. 1088, Chuansha Road, Shanghai, Pudong New Area Patentee before: Shanghai Tehua Medicine Science and Technology Co., Ltd. Patentee before: Topharman Shandong Co., Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160217 Address after: 262123 No. 49 Wen Bei Road, Anqiu Economic Development Zone, Shandong, Weifang Patentee after: Shandong Topharman Pharmaceutical Co., Ltd. Address before: 201209 No. 1088, Chuansha Road, Shanghai, Pudong New Area Patentee before: Shanghai Tehua Medicine Science and Technology Co., Ltd. Patentee before: Shandong Topharman Pharmaceutical Co., Ltd. |